PCVX FY 2022 Earnings — Vaxcyte, Inc. Revenue & Financial Results | Market Cap Arena

PCVXVaxcyte, Inc.

$9B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$232M

Net Income

-$223M

EPS (Diluted)

$-3.44

Cash Flow

Operating Cash Flow

-$171M

Free Cash Flow

-$176M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$53M

Stockholders' Equity

$954M

Cash & Equivalents

$835M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$232M	-$104M	-124.0%
Net Income	-$223M	-$100M	-123.3%